ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,938Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 252

$663K Total Retail Price of All Prescriptions

Rank: 55 out of 252

369 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 369 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 13,152 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
FUROSEMIDE 802 760 1 7
GABAPENTIN 796 774 2 11
LEVOTHYROXINE SODIUM 741 706 3 1
POTASSIUM CHLORIDE 638 625 4 8
FAMOTIDINE 426 393 5 59
SIMVASTATIN 356 306 6 2
AMLODIPINE BESYLATE 339 339 7 4
DONEPEZIL HCL 299 299 8 28
LISINOPRIL 290 277 9 3
NAMENDA 289 289 10 41
CLONIDINE HCL 273 259 11 35
MIRTAZAPINE 272 271 12 58
ESCITALOPRAM OXALATE 234 234 13 56
QUETIAPINE FUMARATE 208 187 14 77
METOPROLOL TARTRATE 194 169 15 10
KLOR-CON M20 183 179 16 69
WARFARIN SODIUM 178 178 17 14
OMEPRAZOLE 148 145 18 6
SERTRALINE HCL 146 146 19 27
CEPHALEXIN 143 139 20 121
CITALOPRAM HBR 138 138 21 15
ATENOLOL 132 132 22 18
CEFTRIAXONE 125 125 23 274
CLOPIDOGREL 123 123 24 29
DIVALPROEX SODIUM 123 87 24 113
VENLAFAXINE HCL 111 99 26 160
METFORMIN HCL 111 84 26 9
LIDOCAINE HCL 105 105 28 258
OXCARBAZEPINE 102 88 29 204
HYDROCHLOROTHIAZIDE 100 88 30 13
ALBUTEROL SULFATE 99 99 31 170
NOVOLIN R 98 98 32 190
SEROQUEL 97 91 33 149
PLAVIX 95 95 34 43
DIGOXIN 95 95 34 44
TRIMETHOPRIM 94 94 36 292
RISPERIDONE 92 92 37 81
IPRATROPIUM-ALBUTEROL 90 89 38 155
AZITHROMYCIN 88 81 39 37
TAMSULOSIN HCL 87 87 40 26
LOSARTAN POTASSIUM 86 86 41 24
TRAZODONE HCL 84 82 42 31
CARVEDILOL 83 70 43 22
OLANZAPINE 79 79 44 191
LEXAPRO 75 74 45 224
HYDROCODONE-ACETAMINOPHEN 75 55 S3 45 5
CYMBALTA 75 69 45 45
HALOPERIDOL 74 74 48 193
KLOR-CON M10 74 74 48 152
METOPROLOL SUCCINATE 74 74 48 19
PREDNISONE 69 57 51 42
CARBIDOPA-LEVODOPA 68 68 52 107
LANTUS 68 68 52 55
SPIRONOLACTONE 66 54 54 53
LATANOPROST 64 64 55 322
LEVETIRACETAM 62 58 56 131
HUMULIN N 61 60 57 247
PAROXETINE HCL 61 49 57 75
ISOSORBIDE DINITRATE 57 51 59 250
ATORVASTATIN CALCIUM 55 55 60 16
LEVOFLOXACIN 55 52 60 79
PHENYTOIN SODIUM EXTENDED 54 41 62 103
EXELON 54 53 62 154
LAMOTRIGINE 53 23 64 165
HUMULIN R 53 52 64 202
DORZOLAMIDE-TIMOLOL 52 52 66 347
BUSPIRONE HCL 50 50 67 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 21, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.